🇺🇸 FDA
Pipeline program

MRG003

MRG003-004

Phase 2 small_molecule active

Quick answer

MRG003 for Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck is a Phase 2 program (small_molecule) at Shanghai University of Traditional Chinese Medicine with 1 ClinicalTrials.gov record(s).

Program details

Company
Shanghai University of Traditional Chinese Medicine
Indication
Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials